• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help...

cafead

Administrator
Staff member
  • cafead   Sep 14, 2020 at 10:22: AM
via Eli Lily & Co. and Incyte Corp. said Monday that their rheumatoid arthritis drug Olumiant helped reduce recovery time in hospitalized COVID-19 patients when it was used in combination with Gilead Sciences Inc.'s remdesivir.

article source
 

<